Skip to main content
Premium Trial:

Request an Annual Quote

WVU Buys Affy System for $300K; Plans Work on Diabetes, Stroke, Brain Disorders

NEW YORK, April 18 (GenomeWeb News) - The University of West Virginia has invested $300,000 on a microarray platform from Affymetrix, according to a local news report.


The Dominion Post in Morgantown, WV, reported last week that WVU recently purchased the system with the intent of studying diabetes, strokes, and brain disorders. The equipment was funded by the National Institutes of Health, the WVU Health Sciences Strategic Research Plan and private donations to the WVU Eye Institute, the report stated.

Sepideh Zareparsi, an assistant professor at the WVU Eye Institute, said she will use the platform to research diabetic retinopathy, which is known to cause blindness.

Thomas Saba, associate vice president for WVU health sciences' research and graduate studies outlined some areas of interest at WVU, noting that West Virginiansare prone to several conditions that have a genetic component, including diabetes, obesity, stroke, and diseases of the brain and nervous system, the report stated.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more